There is so much to be excited about the amazing products and intellectual property of this company. My only concern is if there is the plan to grow into a world class health care and biotech, why have the board not communicated this to shareholders. Unblinded vax results should be accompanied by a date when it is expected to be a stand alone cash flow positive business. They would surely have done the modeling and know the timeline.
There is so much to be excited about the amazing products and...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.21 |
Change
0.010(0.10%) |
Mkt cap ! $215.8M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.50 | $10.06 | $60.58K | 5.907K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3223 | $10.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.49 | 94 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |